Wednesday, March 27, 2019 11:01:48 AM
GPL Filings
Great Panther acquired 100% of the issued and outstanding shares of Beadell through the issuance of 103,593,043 Great Panther shares to Beadell shareholders, representing approximately 38% of the post-Acquisition issued and outstanding Great Panther shares. The share exchange represents a ratio of 0.0619 Great Panther shares for each Beadell share.
Offer to Purchase Outstanding Debentures
As disclosed in Great Panther's news release dated November 30, 2018 and its information circular in connection with the Acquisition, Great Panther will now proceed to make an offer (the "Offer") to purchase for cash Beadell's outstanding US$10,000,000 principal amount, 6.00% convertible senior secured debentures maturing on June 30, 2023 (the "Debentures") at a price equal to 105% of the principal amount, plus accrued and unpaid interest. The Offer will be open for acceptance until April 3, 2019. Great Panther will provide a further update on the earlier of acceptance by all holders of the Debentures of the Offer, or expiry of the Offer. Any Debentures that are not purchased in the Offer will remain outstanding and will be guaranteed by Great Panther and convertible into Great Panther common shares further to a supplemental indenture to the original indenture governing the Debentures. Details of the Offer will be provided in a notice of the Offer to be mailed to the holders of the Debentures.
A debenture is one of the most typical forms of long term loans that a company can take. It is normally a loan that should be repaid on a specific date, but some debentures are irredeemable securities (sometimes referred to as perpetual debentures). The majority of debentures come with a fixed interest rate.
Combining Great Panther and Beadell's respective guidance adds to approximately 200,000 of gold equivalent ounces for 2019 and positions the Company in the ranks of intermediate producers.
There's a sucker born every minute!
-Some Circus Dude
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM